Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C2 | P52895 | 8/20 | 0.57 |
| ▸ | AKR1C1 | Q04828 | 8/20 | 0.57 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30632048 | 1.00 | AKR1C2 (0.57) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL30296240 | 0.96 | AKR1C2 (0.53) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL1513825 | 0.86 | AKR1C2 (0.63) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL11763697 | 0.82 | HSD17B10 (0.52) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL14273026 | 0.82 | AKR1C2 (0.57) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL1437003 | 0.81 | CYP3A4 (0.48) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL2149302 | 0.81 | AKR1C2 (0.52) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL7005963 | 0.81 | AKR1C2 (0.52) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| SCHEMBL28883530 | 0.81 | AKR1C2 (0.52) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD | |
| Fluoride SCHEMBL6445648 | 0.79 | CYP3A4 (0.47) | AKR1C2AKR1C1AKR1C4AKR1C3HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-214437895-U | Trichlorosalicylic acid hydrolysis acid gas absorption device capable of automatically cleaning | 山东博苑医药化学股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-106893343-B | Cyanine compound, colored curable resin composition containing same, color filter and display device containing same | 东友精细化工有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-214437895-U | Trichlorosalicylic acid hydrolysis acid gas absorption device capable of automatically cleaning | 山东博苑医药化学股份有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-214437895-U | Trichlorosalicylic acid hydrolysis acid gas absorption device capable of automatically cleaning | 山东博苑医药化学股份有限公司 | 2021-10-22 | — | — | CN | disclosed |
| US-20210302320-A1 | MOISTURE DETECTION METHOD AND MOISTURE DETECTION SYSTEM | MORESCO CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| CN-112437878-A | Moisture detection method and moisture detection system | 株式会社MORESCO | 2021-03-02 | — | — | CN | disclosed |
| CN-111200935-A | Dicamba compositions with reduced spray drift potential | 美国陶氏益农公司 | 2020-05-26 | — | — | CN | disclosed |
| US-20190116788-A1 | DICAMBA COMPOSITIONS WITH REDUCED SPRAY DRIFT POTENTIAL | DOW AGROSCIENCES LLC (US) | 2019-04-25 | — | — | US | disclosed |
| US-20190116788-A1 | DICAMBA COMPOSITIONS WITH REDUCED SPRAY DRIFT POTENTIAL | DOW AGROSCIENCES LLC (US) | 2019-04-25 | — | — | US | disclosed |
| WO-2019079236-A1 | DICAMBA COMPOSITIONS WITH REDUCED SPRAY DRIFT POTENTIAL | DOW AGROSCIENCES LLC (US) | 2019-04-25 | — | — | WO | disclosed |
| US-8283280-B2 | Reforming catalyst preparation by dry impregnation | IFP Energies Nouvelles (FR) | 2012-10-09 | — | — | US | disclosed |
| US-20100285953-A1 | REFORMING CATALYST PREPARATION BY DRY IMPREGNATION | IFP (FR) | 2010-11-11 | — | — | US | disclosed |
| US-7234827-B2 | Chemiluminescent device | LUMICA CORPORATION (JP) | 2007-06-26 | — | — | US | disclosed |
| US-20040141310-A1 | Chemiluminescent device | LUMICA CORPORATION (JP) | 2004-07-22 | — | — | US | disclosed |
| EP-1018927-A1 | LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION | Laboratoires Piette International S.A. (BE) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999016342-A1 | LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION | LABORATOIRES PIETTE INTERNATIONAL S.A. (BE) | 1999-04-08 | — | — | WO | disclosed |
| US-5194666-A | Intermediates for chemiluminescent agents, chlorination, esterification | AMERICAN CYANAMID COMPANY (US) | 1993-03-16 | — | — | US | disclosed |
| US-5194666-A | Intermediates for chemiluminescent agents, chlorination, esterification | AMERICAN CYANAMID COMPANY (US) | 1993-03-16 | — | — | US | disclosed |
| US-4308395-A | Processes for preparing 3,5,6-trichlorosalicylic acid and esters thereof | AMERICAN CYANAMID COMPANY (US) | 1981-12-29 | — | — | US | disclosed |
| US-3973001-A | Tissue cell stimulating blood extracts | SOLCO BASEL AG (CH) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190116788-A1 | DICAMBA COMPOSITIONS WITH REDUCED SPRAY DRIFT POTENTIAL | DDT, CDA, SGMS1 | AKR1C2 3685/4885AKR1C1 3661/4885AKR1C4 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.